EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Update on the Clinical and Molecular Characterization of Noonan Syndrome and Other RASopathies: A Retrospective Study and Systematic Review

Giuseppe Reynolds iD, Andrea Gazzin iD, Diana Carli iD, Stefania Massuras, Simona Cardaropoli iD, Maria Luca iD, Beatrice Defilippi, Marco Tartaglia iD, Giovanni Battista Ferrero, Alessandro Mussa

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26083515 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Giuseppe Reynolds und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health and Pediatrics, Postgraduate School of Pediatrics, University of Torino, 10126 Turin, Italy. Hauptthemen laut MEDLINE: Noonan Syndrome. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Association of Patients with Noonan Syndrome and RASopathies (www.sindromedinoonan.org), Italian Ministry of Health, Italian National Association of Noonan Syndrome and RASopathies.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RASopathies are a diverse group of genetic conditions caused by hyperactivation of the RAS-MAPK signaling pathway, mainly inherited in an autosomal dominant manner. They present with variable features such as short stature, congenital heart defects, facial dysmorphisms, and neurodevelopmental delays. This study retrospectively analyzed 143 cases from 2003 to 2022, aiming to improve genotype–phenotype correlation knowledge for personalized care. Patients with genetically confirmed Noonan syndrome (NS) and related disorders were included, with molecular analysis performed via Sanger or parallel sequencing. Data from 906 previously reported cases were also reviewed. Among the 143 patients, most had NS (n = 116). PTPN11 mutations were most frequent (61%), followed by SOS1 (10.3%) and RAF1 (8.6%). Cardiac anomalies were observed in 71%, with pulmonary stenosis (PS) prevalent in NS (48.3%) and hypertrophic cardiomyopathy (HCM) in NSML (40%). PTPN11 variants were linked to PS and atrial septal defects, SOS1 to multiple cardiopathies, and RAF1 to HCM. Additional features included facial dysmorphisms (74.1%), short stature (62.0%), skeletal anomalies (43.1%), cryptorchidism (59.7%), and brain abnormalities (17.2%). JMML and other malignancies were seen in eight patients. This study emphasizes the importance of genotype-guided care, improved diagnosis of mild cases, and the underrecognized prevalence of neurological anomalies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Noonan SyndromeHumansRetrospective StudiesProtein Tyrosine Phosphatase, Non-Receptor Type 11MutationSOS1 ProteinMaleFemaleGenetic Association StudiesChildProto-Oncogene Proteins c-rafAdolescentPhenotypeChild, Preschool

Stichwörter der Autor:innen

PTPN11RAF1RAS/MAPK pathwaySOS1congenital disorders

Substanzen

Protein Tyrosine Phosphatase, Non-Receptor Type 11PTPN11 protein, humanSOS1 ProteinRaf1 protein, humanSOS1 protein, humanProto-Oncogene Proteins c-raf

Autor:innen und Institutionen

  • Department of Public Health and Pediatrics, Postgraduate School of Pediatrics, University of Torino, 10126 Turin, Italy.
  • Department of Public Health and Pediatric Sciences, University of Torino, 10126 Turin, Italy.
  • Clinical Pediatrics Genetics Unit, Regina Margherita Children's Hospital, 10126 Turin, Italy.
  • Department of Medical Sciences, University of Turin, 10126 Turin, Italy.
  • Molecular Genetics and Functional Genomics, Bambino Gesù Children's Hospital, IRCCS, 00146 Rome, Italy.
  • Department of Clinical and Biological Sciences, University of Turin, 10043 Orbassano, Italy.

ORCID-Profile: Giuseppe Reynolds, Andrea Gazzin, Diana Carli, Simona Cardaropoli, Maria Luca, Marco Tartaglia

Förderung

  • Italian Association of Patients with Noonan Syndrome and RASopathies (www.sindromedinoonan.org)
  • Italian Ministry of Health
  • Italian National Association of Noonan Syndrome and RASopathies

Zitieren

APA

Reynolds, G., Gazzin, A., Carli, D., Massuras, S., Cardaropoli, S., Luca, M., Defilippi, B., Tartaglia, M., Ferrero, G. B., & Mussa, A. (2025). Update on the Clinical and Molecular Characterization of Noonan Syndrome and Other RASopathies: A Retrospective Study and Systematic Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26083515

Vancouver

Reynolds G, Gazzin A, Carli D, Massuras S, Cardaropoli S, Luca M, et al. Update on the Clinical and Molecular Characterization of Noonan Syndrome and Other RASopathies: A Retrospective Study and Systematic Review. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26083515

BibTeX
@article{Reynolds2025,
  author = {Reynolds, Giuseppe and Gazzin, Andrea and Carli, Diana and Massuras, Stefania and Cardaropoli, Simona and Luca, Maria and Defilippi, Beatrice and Tartaglia, Marco and Ferrero, Giovanni Battista and Mussa, Alessandro},
  title = {Update on the Clinical and Molecular Characterization of Noonan Syndrome and Other RASopathies: A Retrospective Study and Systematic Review},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26083515}
}
Kostenlos starten →